Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3169 of 6351
-
Can a hope program lift spirits during lung cancer treatment?
Symptom relief Recruiting nowThis study will compare the effects of a brief supportive intervention, called Pathways, against enhanced usual care on the mental health and quality of life of people undergoing treatment for advanced lung cancer. Patients will complete baseline survey measures and be randomized…
Sponsor: Laurie McLouth • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Experimental drug combo for rare sarcoma shows promise, but trial halted early
Disease control Stopped earlyTo compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.
Phase 3 • Sponsor: Polaris Group • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail aims to fight stomach cancer in the abdomen
Disease control OngoingThis phase Ib trial test effects of aldesleukin in combination with nivolumab and standard chemotherapy in treating patients with gastric cancer that has spread to the tissue lining of the abdomen (peritoneal metastasis). Aldesleukin is similar to a protein that naturally exists …
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Soundwave therapy shows promise for chemo nerve damage
Symptom relief OngoingThe goal of this clinical trial is to assess the efficacy of SensoniQ® Treatment Station in preventing or reducing chemotherapy induced peripheral neuropathy symptoms (CIPNS) in patients receiving frontline carboplatin and paclitaxel chemotherapy for a gynecologic malignancy. Thi…
Sponsor: Augusta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New drug LX9211 aims to ease diabetic nerve pain
Symptom relief CompletedEvaluation of the efficacy of LX9211 compared to placebo in reducing DPNP. Please see study website: https://diabeticpainstudy.com/
Phase 2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Laser treatment shows promise for easing knee arthritis pain
Symptom relief CompletedThe goal of this clinical trial was to determine whether high-intensity laser therapy (HILT) combined with exercise improves pain, physical function, and muscle strength in people with knee osteoarthritis. The main questions the study aimed to answer were: * Did HILT combined w…
Sponsor: Universidad Metropolitana de Ciencias de la Educacion • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Can better sleep ease Crohn's symptoms? new study investigates
Symptom relief OngoingThe purpose of this study is to assess whether the investigators can treat insomnia in people with Crohn's disease, and if insomnia treatment can make other things better, like pain or inflammation.
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Can better communication reduce breast cancer disparities? new study recruits 3,300 women.
Knowledge-focused Recruiting nowPhase 4 of the Carolina Breast Cancer Study (CBCS4) builds on prior phases that examined molecular and epidemiologic differences in breast cancer types and outcomes. Previous findings showed that certain breast cancer subtypes and genetic factors are linked to higher risks. While…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New study aims to get more heart patients into rehab
Disease control OngoingThe goal of this study is to determine whether participation in a tailored cardiac rehabilitation program delivered in a safety net setting, compared to usual care referral to an outside cardiac rehabilitation program, results in greater participation in cardiac rehabilitation.
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can music and mindfulness ease the toll of stem cell transplants?
Symptom relief CompletedThe goal of this study is to pilot test an Electronic Health Mindfulness-based Music Therapy Intervention (eMBMT) intervention to improve health-related quality of life (HRQoL) and reduce symptom burden of patients undergoing allogeneic stem cell transplantation (allo-SCT).
Sponsor: University of Miami • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Why do stem cell survivors feel exhausted? new study digs into brain inflammation.
Knowledge-focused Recruiting nowPatients undergoing allogenic stem cell transplantation are regularly followed up in the outpatient clinic at Karolinska University Hospital. Here, patients are offered participation the fatigue study measuring both fatigue and cognitive impairment systematically by international…
Sponsor: Karolinska University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:15 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control CompletedA Phase I/Ib, First-In-Human, Multi-Part, Open-Label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of DF6215 Monotherapy and in Combination Therapy in Patients with Advanced (Unresectable, Recurrent, or Metastatic) Solid Tumors;…
Phase 1 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New supplement trial aims to fight chemo fatigue in breast cancer patients
Symptom relief Recruiting nowThe goal of this clinical trial is to test the effect of the administration of APPORTAL® in addition to the SoC (recommended physical exercise), in patients with breast cancer, suffering from fatigue during neoadjuvant and adjuvant chemotherapy. The main questions it aims to answ…
Sponsor: Pharmanutra S.p.a. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Timing of MS drug may change disease course
Disease control Recruiting nowThis non-interventional study will compare the effect of Ofatumumab treatment between patients that began Ofatumumab within the 3 years after Multiple Sclerosis diagnosis and patients that began Ofatumumab with more than 3 years of Multiple Sclerosis diagnosis in a real-world set…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New hope for vitiligo: experimental drug aims to restore skin color
Disease control Stopped earlyResearchers are looking for a new way to treat people with non-segmental vitiligo (NSV). The goal of this study is to learn about the safety of MK-6194 and how well people tolerate it. Researchers also want to learn if people who take MK-6194 have more of a decrease in the amount…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Nasal spray shows promise for tough asthma in early trial
Disease control CompletedThis clinical trial aims to investigate patients with poorly controlled, moderate to severe eosinophilic asthma. The main questions it seeks to answer are 1. Could the AD17002 intranasal immunomodulator improve the clinical condition of eosinophilic asthmatic patients? 2. Could …
Phase 1/2 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:35 UTC
-
New hope for advanced cancer: experimental drug DR30206 enters human testing
Disease control Recruiting nowThis study is to characterize the safety,tolerability, pharmacokinetics(PK),and preliminary anti-tumor activity of DR30206, in subjects with advanced or metastatic solid tumors
Phase 1 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New cancer drug combo enters first human tests
Disease control OngoingThis is a first-in-human Phase I, open-label, dose-escalation and expansion study designed to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, pharmacodynamic, and preliminary anti-tumor activity of RO7566802 as a single agent and in combination with atezolizu…
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Diet and exercise program tested in men with advanced prostate cancer
Disease control Recruiting nowThe proposed pilot study aims at determining the feasibility of a lifestyle intervention including adherence to a personalised dietary regimen combined with regular physical activity in patients newly diagnosed with prostate cancer under androgen deprivation therapy.
Sponsor: Oncology Institute of Southern Switzerland • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New screening tool aims to catch lung disease early in arthritis patients
Knowledge-focused CompletedThe overall aim of the study is to develop and validate a Rheumatoid Arthritis-Interstitial Lung Disease (RA-ILD) clinical prediction model (screening tool) based on risk factors to guide screening for ILD in patients with RA using High Resolution Computed Tomography (HRCT).
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC